European Commission logo
English English
CORDIS - EU research results
CORDIS

The Role of Complex I Assembly Factors during Prion Diseases: Insights into Mitochondrial Neurobiology

Periodic Reporting for period 1 - Prion Respiration (The Role of Complex I Assembly Factors during Prion Diseases: Insights into Mitochondrial Neurobiology)

Reporting period: 2019-10-01 to 2021-09-30

Mitochondria have a crucial role in cell survival and apoptosis, in particular in long-lived cells such as neurons. Mitochondria generate energetic potential through respiratory complexes I to IV, which constitute the electron transport chain. Mitochondrial integrity declines as a function of aging and mitochondrial dysfunctions may be exacerbated by age-related neurodegenerative diseases. Altered levels of Complex I (CI) proteins have been found to be responsible for a decrease in energy production in Alzheimer’s and Parkinson’s diseases. A number of nuclear encoded mitochondrial proteins, denoted as assembly factors (AF), have been identified as crucial CI components helping the CI assembly. Defects in AF may cause CI misassembly and mitochondrial dysfunctions leading to a broad spectrum of fatal diseases including Leigh’s syndrome.
The functional role of AF during neurodegeneration has not been investigated yet. The “Prion Respiration” project aims to elucidate the biological role of three crucial AF -called ECSIT, NDUFAF1 and ACAD9- in neuronal cellular models using prion diseases (also referred as transmissible spongiform encephalopathies or TSE) as robust system to study neurodegeneration. Neuroblastoma N2a cells chronically infected by prions are well-known models to study TSE and have been never used for investigating the role of AF during prion diseases.
The functional characterization of key proteins involved in mitochondrial respiration may provide insights into the underlying mechanisms involved in neuronal function and allow the identification of novel targets to prevent or diminish the oxidative stress during neurodegeneration.
In this research project mass spectrometry and regular protein detection methods have been used to identify a series of proteins with modified expression levels in mitochondria isolated from cells infected with two different prion isolates, also referred as “strains”: the 22L and RML prion strains.
We identified modified protein expression patterns in relation with the prion strains used for the infection. In 22L-infected N2a cells a main upregulation of proteins associated with protein misfolding was observed, while N2a cells infected with the RML prion strain showed downregulation of proteins involved in OXPHOS. Then, western blotting analysis unveiled altered expression levels of AF proteins, such as ECSIT and NDUFAF1.
Altogether our data provide molecular information linking prion infection, mitochondrial dysfunctions and AF alterations, which could be the basis of further therapeutic and pathophysiological research in prion field.
Within the “Prion Respiration” project we used N2a cells as model to investigate the proteomic consequences following the infection of two different prion strains, denotes as 22L and RML.
The relative apparent abundance of the proteins between sample groups has been examined with the goal of comparing the global effects of two prion strains on the proteome profiles of isolated mitochondria from uninfected and prion infected N2a cells. A total of 72 and 87 differentially expressed proteins (DEP) was identified in RML and 22L prion infected cells, respectively. Interestingly, these DEP have a strong association with each prion strain suggesting a strain dependent effect on the mitochondrial proteome.
Conserved DEP among the two cell lines include upregulated proteins involved, for instance, in the regulation of reactive oxygen species, while down-regulated DEP mainly include functions such as mitochondrion organization and calcium homeostasis.
More specifically, the RML prion infection resulted in the down-regulation of proteins involved in the oxidative phosphorylation system, OXPHOS, including CI, CIV and CV subunits, assembly factors and electron transfer components. Mitochondria from N2a cells infected with the 22L prion strain display different DEP signatures with mainly upregulated proteins involved in the oxidative stress response and protein unfolding response.
Proteomic differences in the OXPHOS observed in RML and 22L prion-infected cells may have an impact on the expression levels of key scaffolding proteins responsible for respiratory complexes formation as the AF. To test this hypothesis we run WB experiments using antibodies targeting three key AF such as ACAD9, ECSIT and NDUFAF1 and the CI subunit NDUFV1 and the outer membrane mitochondrial channel VDAC1.
We examined whether the chemical induction of mitochondrial dysfunctions cause severe changes in the expression levels of these proteins compared to untreated cells. The antibiotic chloramphenicol (Chl) was used as mitochondrial inhibitor able to cause OXPHOS dysfunctions.
Analysis on total protein content in the untreated cells showed that ACAD9 expression levels remain constant in the three cell lines, while ECSIT and NDUFAF1 are upregulated in both 22L and RML prion-infected cells. NDUFV1 levels appear down-regulated in 22L and RML N2a cells suggesting a decrease in the content of CI subunits as documented in our differential proteomic analysis.
We propose that the increased expression of these AF components represents an adaptative change of the cell to reduced levels of CI, as inferred by our proteomic analysis. During prion replication, AF may be required to stabilize partially assembled and intermediate modules of CI in cases where CI subunits are damaged, poorly expressed or assembly is compromised.
This preliminary study lays the foundation for further investigation on proteomic and cell biology experiments on the role of AF during different neurodegenerative diseases using different cellular and in vivo models for neurodegeneration.
The rationale of the “Prion Respiration” project and these preliminary results have been disseminated through international congresses and seminars. These events include: one poster presentation (at the “ESRF User Meeting 2020”, February 3-5 2020,Grenoble, France), one oral presentation in a congress (1st Italian Crystallographic Association - Biological Macromolecules Group Meeting, February 20-21 2020, Fiesole, Italy), one seminar at the University of Verona – Italy (on November 8 2019) and two seminars at the University of Trento – Italy (on November 11 2019 and on April 28 2020).
Mitochondrial diseases are the most common group of inherited devastating metabolic disorders and are among the most common forms of fatal inherited neurological disorders. Many strategies have been investigated so far, but currently there is no approved drug that can alleviate disease symptoms or slow disease progression.
The results obtained within the “Prion Respiration” project may represent a novel advancement in the field of mitochondrial neurobiology community in Europe by the first identification of the AF role during prion replication in a cellular model for a neurodegenerative disease, as prion diseases. This knowledge may have a pivotal importance to open new research lines aimed to better characterize the AF function and structure, and to identify new players during neurodegeneration.
Understanding how mitochondrial defects parallel neurodegeneration provides new basis for more effective therapeutic strategies. Indeed, the structural characterization of key proteins, such as the AF, involved in CI formation emerges as a promising approach for mitochondria-targeted therapeutics.
Graphical summary of the “Prion Respiration” project